Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-08

Clinical Trial Update: Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

View source ↗

Summary

Completed clinical trial evaluating EMR-derived covariates in patients with type 2 diabetes treated with oral and non-insulin injectable hypoglycemic therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Non-insulin injectable hypoglycemic therapy (not specified)
  • Oral hypoglycemic therapy (not specified)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2017-02-08